The September 2025 death of 19-year-old California law student Josephine Nasr in her University of East London dorm room has been linked by an East London Coroner’s Court to the prescribed weight-loss drug Tirzepatide, with pathologist Alan Bates and Coroner Graeme Irvine attributing the fatal cardiac arrhythmia to an electrolyte imbalance stemming from drug-induced vomiting and hypoglycemia.
The inquest findings bring to light interactions between incretin-based therapeutics, acute gastrointestinal side effects, and pre-existing structural cardiac anomalies.
Clinical Breakdown: How Tirzepatide Interacts with Metabolism and Cardiac Rhythm
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, known under brand names such as Mounjaro for type 2 diabetes and Zepbound for weight management and obstructive sleep apnea. According to the Mayo Clinic, the weight loss drug can cause side effects such as vomiting and nausea.
In Nasr’s case, autopsy findings revealed a congenital heart condition known as myocardial bridging, which can cause arrhythmia.
The coroner’s court heard that severe vomiting induced acute hypoglycemia (low blood sugar) and subsequent electrolyte imbalances. This metabolic stress created a vulnerable physiological environment that triggered a fatal cardiac arrhythmia in a patient who had a body mass index indicating she was overweight, rather than clinically obese, at the time of her prescription.
Regulatory Oversight and Transatlantic Prescription Practices
The circumstances surrounding Nasr’s death involve the medication being prescribed by a doctor in California while she was studying abroad in the United Kingdom.
| Parameter | Clinical Detail |
|---|---|
| Primary Mechanism | Dual GIP and GLP-1 receptor agonism. |
| Common Adverse Effects | Nausea and vomiting. |
| Severe Risk Factors | Electrolyte disturbances, hypoglycemia, and arrhythmia vulnerability. |
| Regulatory Status | Known under brand names Mounjaro for type 2 diabetes treatment and Zepbound for weight management and obstructive sleep apnea. |
In Plain English: The Clinical Takeaway
- Understand the Side Effects: Nausea and vomiting from weight-loss injections can cause electrolyte imbalances.
- Know Your Anatomy: Undiagnosed congenital heart conditions, such as myocardial bridging, can make the heart vulnerable to arrhythmia.
References
- nypost.com
